-
Dr. Nigel Russell: The Latest International Treatment Advances in Acute Myeloid Leukemia
Abstract: Dr. Nigel Russell provides insights into the recent developments in the treatment landscape of Acute Myeloid Leukemia (AML). The discussion encompasses the combination of FLT3 mutation inhibitors with intensive chemotherapy, emphasizing the effectiveness and safety demonstrated by the combination of midostaurin with gemtuzumab ozogamicin. The presentation explores emerging FLT3 inhibitors like quizartinib and their…
-
Dr. Niels Van de Donk: Navigating the Horizon of CAR-T Treatment for RRMM
Editor’s Note: In this captivating interview, Dr. Niels Van de Donk offers an extensive exploration of the recent advancements and future prospects in Chimeric Antigen Receptor T-cell (CAR-T) therapy for relapsed/refractory multiple myeloma (RRMM). Dr. Donk’s insights, ranging from the dynamic landscape of CAR-T targets to pivotal studies like MAJESTEC-1, provide a comprehensive overview of…
-
Professor SiZhou Feng : The Application of mNGS in Hematological Infections and the Optimization of Empirical Treatment Plans for Neutropenia-Associated Fever
Editor’s Note: At the recently held Fourth China Hematology Development Conference, the “Chinese Expert Consensus on the Application of Metagenomic Next-Generation Sequencing (mNGS) in the Diagnosis of Infectious Pathogens in…
-
Multidisciplinary Perspective: Professor MingGui Wang Shares Insights on the Application of mNGS in Blood Disease Infection Detection and Progress in Global CRO New Drug Treatment
Infectious Disease Frontline: The “Chinese Expert Consensus on the Application of Metagenomic Next-Generation Sequencing Technology in the Diagnosis of Pathogens in Blood Disease Infections” has been published. How do you view…
-
Major Announcement! Top 10 Research Advances in Chinese Hematology in 2023 Revealed
On January 7th, the Fourth Chinese Hematology Development Conference unveiled the “Top 10 Research Advances in Chinese Hematology in 2023.” The scientific advancements recommended as the “Top 10 Research Advances…
-
2024 CASH | Professor ZhiJian Xiao : Breaking Through Tradition, Marching Towards the Future, The Perfect Integration of Precision Diagnosis and Digital Science
“Oncology Frontier – Hematology Frontier“: As China’s population ages, the incidence of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) is rising annually. As an expert deeply involved in MDS, MPN,…
-
2024 CASH | Professor XiaoFan Zhu : Immunotherapy Strategy Brings Greater Benefits to Children with ALL
“Oncology Frontier – Hematology Frontier“: In recent years, immunotherapy has made groundbreaking progress in treating pediatric ALL, especially in children with relapsed or refractory ALL. Professor XiaoFan Zhu: The significant improvements in…
-
2024 CASH丨Professor RongFu : Progress in the Study of Hematological Toxicity Related to CAR-T Therapy
From January 5th to 7th, 2024, the 4th China Hematology Science Development Conference (CASH) opened in Tianjin. Professor Rong Fu of Tianjin Medical University General Hospital delivered an insightful lecture titled…
Connecting Medical Expertise through Media